The core activity of Novigenix is the development and application of precision medicine solutions, particularly in the field of cancer early detection and treatment, using liquid biopsy technologies and artificial intelligence (AI) based analysis platforms, such as the LITOSeek platform. The company focuses on researching and developing innovative approaches to cancer treatment, including the identification of new target molecules for drugs and the development of precision medicine approaches for personalized cancer treatment.